tekst 1

Log in

Guide for Authors


The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. Example of a correctly given DOI (in URL format; here an article in the journal Physics Letters B):
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to change.

As a service to the community, this journal makes available online the accepted manuscripts as soon as possible after acceptance. At this stage, the author's accepted manuscript (in both full-text and PDF) is given a Digital Object Identifier (DOI) and is fully citable, and searchable by title, author(s) name and the full-text. The article also carries a disclaimer noting that it is an unedited manuscript which has not yet been copyedited, typeset or proofread. When the fully copyedited version is ready for publication, it simply replaces the author accepted manuscript version.


Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is essential to the discussion.

The generic (nonproprietary) name of a drug is preferred in almost all instances. If it is necessary to include the brand (proprietary or trade) name for reproduction or interpretation of the study, the brand name should be given parenthetically, following the generic name, at first mention in the abstract, text, and each figure or table in which it appears. In addition, the brand name and supplier’s name and location should be given in the Methods section. In the case in which a manuscript is comparing various brands of a single product, or in which an adverse event is described that might be unique to a single brand of product, both the brand name and generic name should appear at first mention and the brand name(s) should be used thereafter.

Authors submitting manuscripts or letters to the editor regarding adverse drug or medical device reactions, reportable diseases, and the like should also report such to the relevant government agency.


Please cite references with Arabic numbers in squared parentheses and list them by the order in which they appear in the text (not in alphabetical order). References should be numbered consecutively in order of their appearance in the text and listed in numerical order. For references to journal articles, include the first 6 authors, followed by "et al" if there are more than 6 authors. The author names are followed by the title (with only the first word capitalized), the abbreviated name of the journal, the year, volume number (without issue number), and page range. Cite the references in the text by the appropriate number e.g. [1], [2, 3], [4-6], [7, 8-10] and the numbers should be within square brackets. Avoid using abstracts as references. Nothing should be italicized. Journal titles should be abbreviated according to the Index Medicus.

For chapters of books that have an editor(s) and individually authored chapters, include the names of the chapter authors, followed by the chapter title, the book editors, the book title, the city of publication, publisher name, year of publication, and chapter page range.

The list of references should only include works that are cited in the text and that have been published or accepted for publication ("in press"). Personal communications or unpublished data cannot be included in the reference list, but they should be mentioned in the text in parentheses including a date. Permission must be submitted when citing a personal communication. A paper published online but not (yet) in print can be cited using the Digital Object Identifier (DOI).

References with correct punctuation should be styled as follows:

Davì S, Lattanzi B, Demirkaya E, Rosina S, Bracciolini G, Novelli A, et al. Toward the development of new diagnostic criteria for macrophage activation syndrome in systemic juvenile ýdiopathic arthritis. Ann Paediatr Rheum 2012; 1:1-7.

Ozen S, Petty RE. Behcet Disease. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds). Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 561-567, 2005

Online document
The inside story: a guide to indoor air quality. In: U.S. EPA/Office of Air and Radiation Available via http://www.epa.gov/iaq/pubs/insidestory.html (Accessed 18 December 2011).

If the author is unknown

McGwire owns the mark alone. ESPN.com. 8 Nov. 2008. http://ESPN.SportsZone.com/mlb/news/1998/980908/00833812.html (8 Nov.2008).

Oter S. Assessment of lipid peroxidation and antioxidant enzymes to determine oxidant stress in rat lung induced by hyperbaric oxygen treatment at different doses and intervals. Dissertation, Gulhane Military Medical Academy, Ankara, Turkey, 1998.

Article by DOI (digital object identifier)
Polat A, Demirkaya E, Basbozkurt G, Gattorno M, Ozen S. A glance at history and future perspectives of childhood autoinflammatory disorders. Ann Paediatr Rheum 2012; doi: 10.5455/apr.022120120023


Please submit tables as editable text and not as images. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules.